The biggest drug driving Sanofi’s and Regeneron’s businesses is about to get a bit bigger. On Friday, the FDA approved ...

Travere Therapeutics said there is a “voluntary pause” in recruitment to its Phase 3 study in a rare, inherited disorder due ...

Cassava Sciences and two of its former executives have reached a resolution with the SEC over charges for “misleading” ...

While the worst of the funding slump for digital health startups since the lofty highs of the pandemic seems to be drawing to ...

Lavigne Total raised More than $1 billion in committed capital Headquarters South San Francisco, CA David Baker’s Seattle ...

CEO Daphne Zohar Total raised $100 million Headquarters Boston, MA On Thursday, members of Seaport Therapeutics’ founding ...

What makes a great biotech startup? Every year, the Endpoints 11 awards try to answer that question. We've spent the last ...

One of the original AI-driven drug discovery and development biotechs has let its plans to list on the Hong Kong stock ...

The FDA lifted a clinical hold on two trials testing Biomea Fusion’s diabetes treatment. The news, announced Thursday, sent ...

SIGA Technologies said former chief medical officer Jay Varma’s comments about the company’s experimental mpox drug are ...

The FDA on Thursday approved Bristol Myers Squibb’s new schizophrenia drug in one of the year’s most anticipated regulatory decisions. The approval gives Bristol Myers a significant foothold in the ...

Flagship Pioneering is betting $50 million that it can solve one of genetic medicine's biggest problems — how to get the ...